Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02GLM
|
|||
| Former ID |
DNC008936
|
|||
| Drug Name |
2,4-diisobutylamino-6-isopentylpyrimidine
|
|||
| Synonyms |
CHEMBL347927; 2,4-diisobutylamino-6-isopentylpyrimidine; ZINC13559143; BDBM50138886
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H32N4
|
|||
| Canonical SMILES |
CC(C)CCC1=CC(=NC(=N1)NCC(C)C)NCC(C)C
|
|||
| InChI |
1S/C17H32N4/c1-12(2)7-8-15-9-16(18-10-13(3)4)21-17(20-15)19-11-14(5)6/h9,12-14H,7-8,10-11H2,1-6H3,(H2,18,19,20,21)
|
|||
| InChIKey |
FELVKNQXOFEZOY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. J Med Chem. 2008 Oct 23;51(20):6512-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.